ID
35192
Descripción
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the first vital sign measurement and should be filled out at visit 1. All vital signs should be taken in a sitting position
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Palabras clave
Versiones (3)
- 23/2/19 23/2/19 -
- 1/3/19 1/3/19 -
- 10/11/19 10/11/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
23 de febrero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Similar models
Vital Signs
- StudyEvent: ODM
C2985720 (UMLS CUI [1,2])
C0442027 (UMLS CUI [1,2])